Metraipolis › archive › dc_160326328616

Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation — Europe PMC PMID:42218313

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42218313
DOI
10.1007/s10571-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-01T03:09:24.377Z
SHA-256 of the archived text
1af75ed0a31141a7d1a7216933f767a51faf17bc973168f481251b3b364631ca
Stable URL of this page
https://metraipolis.com/documento/dc_160326328616

How to cite

Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation — Europe PMC PMID:42218313 — Europe PMC (en), https://europepmc.org/article/MED/42218313 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_160326328616 (Metraipolis archive dc_160326328616, sha256 1af75ed0a31141a7d1a7216933f767a51faf17bc973168f481251b3b364631ca)
BibTeX
@misc{dc160326328616,
  title = {Hsa-miR-25-3p Inhibition Sensitizes Patient-Derived Glioblastoma Cells to Temozolomide via β-catenin Downregulation — Europe PMC PMID:42218313},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42218313},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_160326328616; sha256 1af75ed0a31141a7d1a7216933f767a51faf17bc973168f481251b3b364631ca},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42218313. Agents can read the archived copy with the MCP tool read_document.